Media

15 December, 2011
Board Room Radio:
"Allied receives positive Tissue Heart Valve study results"
View More...

7 December, 2011
Biotech Daily:
"Allied Healthcare Group update"
View More...

5 December, 2011
Australian Life Scientist:
"Trial demonstrates long life tissue heart valves"
View More...

5 December, 2011
Australian Life Scientist:
"Movers and Shakers"
View More...

25 Octover, 2011
MedicalXPress.com:
"UQ start-up research offers hope for herpes suffers"
View More...

11 October, 2011
Life Scientist:
"Experimental DNA Vaccine gives full protection against herpes"
View More...

11 October, 2011
Biotech Daily:
"Allied Healthcare Group Market Report"
View More...

10 October, 2011
NewsMedical.net:
"Coridon Demonstrates 100% Protection using DNA HSV-2 Vaccine"
View More...

30 September, 2011
4traders.com:
"Allied Healthcare Announces a $5M Equity Funding Package"
View More...

30 September, 2011
BioSpace:
"Allied Healthcare Announces a $5 million Equity Funding Package"
View More...

30 September, 2011
BTD:
"Allied Health $5m Funding"
View More...

30 September, 2011
PBR:
"Allied Healthcare Secures $4.86m Equity Funding for Vaccine Development"
View More...

1 September, 2011
Ahead of the Curve:
"When Resources and Biotech Meet"
View More...

21 July, 2011
Brisbane Times:
"Cancer Vaccine Developer in US Deal"
View More...

21 July, 2011
SMH Online:
"Cancer Vaccine Developer in US Deal"
View More...

21 July, 2011
The Age:
"Cancer Vaccine Developer in US Deal"
View More...

21 July, 2011
West Australian:
"EBV Project on Track to Give Allied Health a Windfall"
View More...

19 July, 2011
AFR:
"Twiggy is Down But Not Out"
View More...

16 July, 2011
The Weekend Australian:
"Forrest-backed Allied Aiming for Drug Lead"
View More...

28 June, 2011
BioTechnology News:
"Billionaires Could FInd Biotechs More Attractive"
View More...

21 June, 2011
Smart Company:
"Andrew Forrest-backed biotech lists on ASX"
View More...

21 June, 2011
Drug Science in Focus:
"Big Name Support for bioMD"
View More...

21 June, 2011
Business Spectator:
"Forrest to Launch Biotech Venture: Report"
View More...

21 June, 2011
Business Spectator:
"bioMD Board Changes"
View More...

21 June, 2011
BioTechnology News:
"Allied Takeover Prompts bioMD Reshuffle"
View More...

21 June, 2011
The Age:
"Biotech Adventure for Twiggy"
View More...

20 June, 2011
BioTech Daily:
"bioMD Board adds Fortescue Muscle, Jet Soedirdja"
View More...

20 June, 2011
BioSpace:
"bioMD Limited Announces Board Changes, Appointment of New MD and Chairman"
View More...

14 June, 2011
Biotech Daily: "bioMD takes 90% of the public unlisted Allied Medical"
View More...

14 June, 2011
The Age:
"Allied close to listing with bioMD"
View More...

16 February, 2011
AFR “bioMD in symbiotic deal with Allied Medical”

If the deal goes through, the combined entity will include the DNA
vaccine development company Coridon. Led by Ian Frazer. The
developer of the Gardasil cervical cancer vaccine, and bioMD’s
regenerative tissue engineering technology for use in cardiovascular
and soft tissue repair.

15 February, 2011
Life Scientist: “ bioMD makes bid for Andrew Forrest’s
Allied Medical and Coridon”
View More...

15 February, 2011
AFR “bioMD makes an offer for unlisted Allied Medical” Perth-based bioMD is offering Allied Medical shareholders 32 bioMD
shares for each Allied share in a deal that values Allied at $38
million.

12 November, 2010
AFR “Stocks to watch on the ASX”

Avexa plans to buy up to 24% of Allied Medical

11 November, 2010
AFR “Avexa to buy 24pc stake in Allied Medical”

11 September, 2010
AFR “ Cancer King’s new drug pitch”

The man who co-created the cervical cancer vaccine claims to have
new ones that can cure other cancers and diseases.

Frazer says the vaccine has already been used to treat tumours
in mice, and save them from 500-times lethal doses of infection.
Frazer hopes to produce vaccines to treat diseases where current
vaccines don’t work.

19 July, 2010
SMH “Forrest shovels millions into vaccines foray”
View More...

19 July, 2010
AGE “Mining magnate invests in biotech”
View More..


Back to top